106 related articles for article (PubMed ID: 35307250)
1. Prognostic impact of inter-metastatic heterogeneity of viable tumour cells in colorectal liver metastases.
Strömberg C; Martinez de la Maza L; Fernández Moro C; Gerling M; Jorns C; Sparrelid E; Löhr MJ; Villard C
Eur J Surg Oncol; 2022 Jul; 48(7):1656-1663. PubMed ID: 35307250
[TBL] [Abstract][Full Text] [Related]
2. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model.
Villard C; Abdelrafee A; Habib M; Ndegwa N; Jorns C; Sparrelid E; Allard MA; Adam R
Eur J Surg Oncol; 2022 Dec; 48(12):2432-2439. PubMed ID: 35786533
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases.
Wang XY; Zhang R; Wang Z; Geng Y; Lin J; Ma K; Zuo JL; Lu L; Zhang JB; Zhu WW; Chen JH
Br J Surg; 2019 Dec; 106(13):1747-1760. PubMed ID: 31386192
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
[TBL] [Abstract][Full Text] [Related]
7. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
Wang K; Xu D; Yan XL; Poston G; Xing BC
Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
[TBL] [Abstract][Full Text] [Related]
8. Conversion therapy in patients with colorectal liver metastases.
Villard C; Habib M; Nordenvall C; Nilsson PJ; Jorns C; Sparrelid E
Eur J Surg Oncol; 2021 Aug; 47(8):2038-2045. PubMed ID: 33640172
[TBL] [Abstract][Full Text] [Related]
9. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
10. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
11. Implication of primary tumor location for the indication of preoperative chemotherapy in patients with colorectal liver metastases.
Imai K; Yamashita YI; Miyamoto Y; Nakao Y; Yusa T; Itoyama R; Nakagawa S; Okabe H; Hiyoshi Y; Nitta H; Chikamoto A; Baba H
HPB (Oxford); 2019 Apr; 21(4):405-412. PubMed ID: 30266494
[TBL] [Abstract][Full Text] [Related]
12. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
[TBL] [Abstract][Full Text] [Related]
13. Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study.
Scherman P; Syk I; Holmberg E; Naredi P; Rizell M
Eur J Surg Oncol; 2021 Feb; 47(2):375-383. PubMed ID: 32828581
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study.
Behrenbruch C; Prabhakaran S; Udayasiri D; Hollande F; Michael M; Hayes I; Heriot A; Knowles B; Thomson B
ANZ J Surg; 2021 Jun; 91(6):1196-1202. PubMed ID: 33543551
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic two-stage hepatectomy for bilobar colorectal liver metastases.
Fuks D; Nomi T; Ogiso S; Gelli M; Velayutham V; Conrad C; Louvet C; Gayet B
Br J Surg; 2015 Dec; 102(13):1684-90. PubMed ID: 26392212
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
18. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
19. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.
Javed S; Benoist S; Devos P; Truant S; Guimbaud R; Lièvre A; Sefrioui D; Cohen R; Artru P; Dupré A; Bachet JB; de la Fouchardière C; Ploquin A; Turpin A
World J Surg Oncol; 2022 Apr; 20(1):131. PubMed ID: 35461290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
